Responses
Clinical pharmacy and clinical trials (including case series)
CPC-124 Rivaroxaban or Conventional Thromboprophylaxis After Major Orthopaedic Surgery in Routine Practise: Influence of Co-Medications on Outcomes in the XAMOS Study
Compose a Response to This Article
Other responses
No responses have been published for this article.